Related references
Note: Only part of the references are listed.TGF-β1 induces erlotinib resistance in non-small cell lung cancer by down-regulating PTEN
Hua Shen et al.
BIOMEDICINE & PHARMACOTHERAPY (2016)
miR-141 is involved in BRD7-mediated cell proliferation and tumor formation through suppression of the PTEN/AKT pathway in nasopharyngeal carcinoma
Y. Liu et al.
CELL DEATH & DISEASE (2016)
MicroRNA-21 induces 5-fluorouracil resistance in human pancreatic cancer cells by regulating PTEN and PDCD4
Xueju Wei et al.
CANCER MEDICINE (2016)
Induction of Epithelial-Mesenchymal Transition and Down-Regulation of miR-200c and miR-141 in Oxaliplatin-Resistant Colorectal Cancer Cells
Shota Tanaka et al.
BIOLOGICAL & PHARMACEUTICAL BULLETIN (2015)
Combined Analysis of EGFR and PTEN Status in Patients With KRAS Wild-Type Metastatic Colorectal Cancer
Yu Chen et al.
MEDICINE (2015)
The miR-200 family differentially regulates sensitivity to paclitaxel and carboplatin in human ovarian carcinoma OVCAR-3 and MES-OV cells
Anamaria Brozovic et al.
MOLECULAR ONCOLOGY (2015)
Fractionated Ionizing Radiation Promotes Epithelial-Mesenchymal Transition in Human Esophageal Cancer Cells through PTEN Deficiency-Mediated Akt Activation (vol 10, e0126149, 2015)
Enhui He et al.
PLOS ONE (2015)
MicroRNA biogenesis pathways in cancer
Shuibin Lin et al.
NATURE REVIEWS CANCER (2015)
miR-141 Is a Key Regulator of Renal Cell Carcinoma Proliferation and Metastasis by Controlling EphA2 Expression
Xuanyu Chen et al.
CLINICAL CANCER RESEARCH (2014)
miR-21 modulates chemosensitivity of tongue squamous cell carcinoma cells to cisplatin by targeting PDCD4
Wenhao Ren et al.
MOLECULAR AND CELLULAR BIOCHEMISTRY (2014)
MicroRNA signatures in chemotherapy resistant esophageal cancer cell lines
Richard Hummel et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2014)
Function of miRNA in Controlling Drug Resistance of Human Cancers
Liu Hong et al.
CURRENT DRUG TARGETS (2013)
miR-200c Inhibits Melanoma Progression and Drug Resistance through Down-Regulation of Bmi-1
Shujing Liu et al.
AMERICAN JOURNAL OF PATHOLOGY (2012)
Drug resistance-related microRNAs in esophageal cancer
Liu Hong et al.
EXPERT OPINION ON BIOLOGICAL THERAPY (2012)
miR-200c Sensitizes Breast Cancer Cells to Doxorubicin Treatment by Decreasing TrkB and Bmi1 Expression
Florian Kopp et al.
PLOS ONE (2012)
Overexpression of miR-200c Induces Chemoresistance in Esophageal Cancers Mediated Through Activation of the Akt Signaling Pathway
Rie Hamano et al.
CLINICAL CANCER RESEARCH (2011)
Esophagogastric Cancer: Integration of Targeted Therapies into Systemic Chemotherapy
M. Moehler et al.
CURRENT CANCER DRUG TARGETS (2011)
The Prognostic and Chemotherapeutic Value of miR-296 in Esophageal Squamous Cell Carcinoma
Liu Hong et al.
ANNALS OF SURGERY (2010)
MiR-222 Overexpression Confers Cell Migratory Advantages in Hepatocellular Carcinoma through Enhancing AKT Signaling
Queenie W-L. Wong et al.
CLINICAL CANCER RESEARCH (2010)
Down-Regulation of miR-27a Might Reverse Multidrug Resistance of Esophageal Squamous Cell Carcinoma
Hongwei Zhang et al.
DIGESTIVE DISEASES AND SCIENCES (2010)
miR-181b modulates multidrug resistance by targeting BCL2 in human cancer cell lines
Wei Zhu et al.
INTERNATIONAL JOURNAL OF CANCER (2010)
Mechanisms of microRNA deregulation in human cancer
Shan Deng et al.
CELL CYCLE (2008)
Targeting multidrug resistance in cancer
G Szakács et al.
NATURE REVIEWS DRUG DISCOVERY (2006)
Multiple management modalities in esophageal cancer: Epidemiology, presentation and progression, work-up, and surgical approaches
M Koshy et al.
ONCOLOGIST (2004)
Share Paper
